Clinical trial
Efficacy and Safety of Ostenil® Plus in the Treatment of Coxarthrosis
NCT03809962 is registered in ClinicalTrials.gov with TRB Chemedica AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Ostenil® Plus in the Treatment of Coxarthrosis
- Lead sponsor
- TRB Chemedica AG
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 15, 2019
- Completion date
- May 14, 2025
- Enrollment
- 170 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
coxarthrosis